NCT04801537

Brief Summary

Bloody stool and necrotizing enterocolitis(NEC) is two main focus in non-neonatal intensive care unit ward and usually lead to longed duration of hospitalization. Neutral temperature is a environmental temperature where the infant's body temperature is normal under resting state, and the changes of body temperature and skin temperature are less than 0.2-0.3 centigrade. According the definition, a suggested temperature range is set. For example, if an infant's body weight is more than 2500 gram, the initial set of environmental temperature is 31.3 centigrade with a range of 29.8-32.8 centigrade. low environmental temperature is a risk factor for Bloody stool and NEC. Therefore, how to set the optimal environmental temperature is a challenge.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2021

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2021

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 12, 2021

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 17, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2024

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

October 14, 2022

Status Verified

October 1, 2022

Enrollment Period

3 years

First QC Date

March 12, 2021

Last Update Submit

October 13, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • bloody stool

    a infant is suffered from bloody stool

    before discharge

  • necrotizing entercolitis(NEC)

    a infant is suffered from NEC

    before discharge

Secondary Outcomes (1)

  • late-onset sepsis(LOS)

    before discharge

Study Arms (2)

normal body temperature and warm extremities

standard set of environmental temperature is done, and the infant's body temperature is normal and extremities are warm

Other: normal body temperature and warm extremities

normal body temperature and cold extremities

standard set of environmental temperature is done, and infant's body temperature is normal and extremities are cold

Other: normal body temperature and cold extremities

Interventions

environmental temperature is set according to the standard method to keep normal body temperature and warm extremities

normal body temperature and warm extremities

environmental temperature is set according to the standard method to keep normal body temperature, but cold extremities

normal body temperature and cold extremities

Eligibility Criteria

Age1 Hour - 28 Days
Sexall
Age GroupsChild (0-17)
Sampling MethodProbability Sample
Study Population

an infant's body weight \> 2500 grams and/or gestational age \>35 weeks is included in the present study.

You may qualify if:

  • body weight \>2500 grams and/or gestational age \>35 weeks
  • an infant is diagnosed with hyperbilirubinemia and/or pneumonia without need for oxygen inhalation

You may not qualify if:

  • congenital deformities
  • refusal of parents' consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chen

Chongqing, Chongqing Municipality, 400014, China

RECRUITING

MeSH Terms

Conditions

Gastrointestinal HemorrhageEnterocolitis, Necrotizing

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System DiseasesHemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsEnterocolitisGastroenteritisIntestinal Diseases

Central Study Contacts

Chen Long, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
director

Study Record Dates

First Submitted

March 12, 2021

First Posted

March 17, 2021

Study Start

January 1, 2021

Primary Completion

January 1, 2024

Study Completion

December 31, 2024

Last Updated

October 14, 2022

Record last verified: 2022-10

Locations